As of March 6, 2026, our covered-call stock portfolio has decreased slightly by -1.16% and closed at $11,211. As our portfolio’s base currency is EUR, the decrease should primarily be attributed…
As of February 20, 2026, our covered-call stock portfolio has increased by +2.20% and closed at $11,312. Growth remained intact, even after rolling PFE forward and down.For most of the week, my…
As of February 13, 2026, our covered-call stock portfolio has decreased slightly by -0.33% and closed at $11,069. Since I couldn’t continue with weekly NVDA spread trades — having already rolled…
Pfizer (PFE) is not a new name in my investing history. I was investing in PFE well before Covid, with fairly high expectations for the stock as a stable pharmaceutical blue-chip with strong cash…
The Small Dogs of the Dow, are the five lowest-priced Dogs of the Dow stocks. Currently (2020), these are the Small Dogs of The Dow stocks: DOW, PFE, WBA, CSCO and KOIn today's article, I will take a…
Selling naked puts on dividend stocks is one of my favorite income-generating strategies. I've been selling options since the end of March 2019, and as a seasoned dividend income investor, I…
I share ongoing portfolio progress with a focus on generating income through covered calls on quality stocks. Each update includes positioning changes, trade rationale, and forward-looking adjustments based on current market conditions.